These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 6818483)

  • 1. [Mytomycin C nephrotoxicity. 3 new cases and review of the literature].
    Simon P; Hervé JP; Ramée MP; Leroy JP; Ang KS; Leguy P; Vignoud J; Cledes J
    Nephrologie; 1982; 3(4):152-7. PubMed ID: 6818483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitomycin-associated renal failure. Case report and review.
    Hamner RW; Verani R; Weinman EJ
    Arch Intern Med; 1983 Apr; 143(4):803-7. PubMed ID: 6340628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Microangiopathic hemolytic anemia (MAHA) observed after administration of mitomycin C (MMC)].
    Yasunaga C; Komota T; Mimura K; Kinjyo M; Sueishi K; Hirose T
    Gan No Rinsho; 1987 Jun; 33(7):854-60. PubMed ID: 3112442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal disease after mitomycin C therapy.
    Hanna WT; Krauss S; Regester RF; Murphy WM
    Cancer; 1981 Dec; 48(12):2583-8. PubMed ID: 6796250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microangiopathic hemolytic anemia, renal failure, and noncardiogenic pulmonary edema: a chemotherapy-induced syndrome.
    Jolivet J; Giroux L; Laurin S; Gruber J; Bettez P; Band PR
    Cancer Treat Rep; 1983 May; 67(5):429-34. PubMed ID: 6406059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Uremic hemolytic syndrome induced by mitomycin C. Presentation of a series of 5 cases and review of the literature].
    Nicolás JM; Villalta J; González-Clemente JM; Antúnez E; Almirall J; Bosch J; Torras A; Urbano-Márquez A
    Rev Clin Esp; 1990 Mar; 186(4):166-70. PubMed ID: 2114657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of mitomycin-associated microangiopathic hemolytic anemia with vincristine.
    Grem JL; Merritt JA; Carbone PP
    Arch Intern Med; 1986 Mar; 146(3):566-8. PubMed ID: 3954531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microangiopathic hemolytic anemia, noncardiac pulmonary edema, and renal failure after treatment of metastatic adenocarcinoma of the colon with 5-fluorouracil and mitomycin-C: report of a case.
    Claycomb CL; Berkovic M
    J Am Osteopath Assoc; 1986 Aug; 86(8):499-503. PubMed ID: 3093413
    [No Abstract]   [Full Text] [Related]  

  • 9. Silent renal microangiography after mitomycin C therapy.
    Poch E; González-Clemente JM; Torras A; Darnell A; Botey A; Revert L
    Am J Nephrol; 1990; 10(6):514-7. PubMed ID: 2127509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Three cases of renal failure associated with microangiopathic hemolytic anemia after mitomycin C therapy].
    Hayano K; Fukui H; Otsuka Y; Hattori S
    Nihon Jinzo Gakkai Shi; 1988 Jul; 30(7):835-42. PubMed ID: 3150472
    [No Abstract]   [Full Text] [Related]  

  • 11. [Nephrotoxicity of mitomycin C (apropos of 25 case reports). Results of a multicenter survey organized by the Society of Nephrology].
    Cordonnier D; Vert-Pré FC; Bayle F; Alix JL; Couderc P
    Nephrologie; 1985; 6(1):19-26. PubMed ID: 3923381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal toxicity of mitomycin-C.
    Ravikumar TS; Sibley R; Reed K; Grage TB
    Am J Clin Oncol; 1984 Jun; 7(3):279-85. PubMed ID: 6428215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal complications of mitomycin C therapy with special reference to the total dose.
    Valavaara R; Nordman E
    Cancer; 1985 Jan; 55(1):47-50. PubMed ID: 3917353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitomycin-induced hemolytic-uremic syndrome.
    Proia AD; Harden EA; Silberman HR
    Arch Pathol Lab Med; 1984 Dec; 108(12):959-62. PubMed ID: 6210069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carcinoma-associated hemolytic-uremic syndrome: a complication of mitomycin C chemotherapy.
    Cantrell JE; Phillips TM; Schein PS
    J Clin Oncol; 1985 May; 3(5):723-34. PubMed ID: 3923162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemolytic-uremic syndrome (HUS): a clinicopathological study of 15 cases.
    Tinaztepe K; Akkök N; Tinaztepe B
    Turk J Pediatr; 1993; 35(1):23-36. PubMed ID: 8236514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glomerular tuft ballooning in mitomycin-C-induced renal impairment.
    Shiiki H; Dohi K; Nishioka H; Matsuda T; Kanauchi M; Uyama H; Ishikawa H; Watanabe T
    Virchows Arch A Pathol Anat Histopathol; 1992; 420(6):545-51. PubMed ID: 1609513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitomycin C associated hemolytic uremic syndrome.
    Jain S; Seymour AE
    Pathology; 1987 Jan; 19(1):58-61. PubMed ID: 3108839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Thrombotic microangiopathy and chronic renal failure caused by mitomycin C in 4 women treated for breast cancer].
    Bayle F; Vialtel P; Bastrenta F; Swiercz P; Dechelette E; Pin I; Carpentier P; Mousseau M; Schaerer R; Couderc P; Cordonnier D
    Nouv Presse Med; 1982 Jun; 11(30):2300-1. PubMed ID: 6810311
    [No Abstract]   [Full Text] [Related]  

  • 20. Mitomycin C-induced renal insufficiency: a case report.
    Wen MC; Chen CH; Ho WL
    Kaohsiung J Med Sci; 2003 Jun; 19(6):317-21. PubMed ID: 12873041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.